Page last updated: 2024-08-22

carbendazim and Leukemia P388

carbendazim has been researched along with Leukemia P388 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Camden, JB; Dexter, DL; Hao, D; Mangold, GL; Marty, J; Moore, RV; Rizzo, JD; Stringer, S; Von Hoff, DD; Weitman, SD	1

Other Studies

1 other study(ies) available for carbendazim and Leukemia P388

Article	Year
Preclinical antitumor activity and pharmacokinetics of methyl-2-benzimidazolecarbamate (FB642). Investigational new drugs, 2002, Volume: 20, Issue:3 Topics: Animals; Antineoplastic Agents; Area Under Curve; Benzimidazoles; Carbamates; Cell Division; Cell Survival; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Leukemia P388; Male; Melanoma, Experimental; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Rats; Rats, Inbred F344; Therapeutic Equivalency; Tumor Cells, Cultured	2002

Article

Year

Preclinical antitumor activity and pharmacokinetics of methyl-2-benzimidazolecarbamate (FB642).

Investigational new drugs, 2002, Volume: 20, Issue:3

Topics: Animals; Antineoplastic Agents; Area Under Curve; Benzimidazoles; Carbamates; Cell Division; Cell Survival; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Leukemia P388; Male; Melanoma, Experimental; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Rats; Rats, Inbred F344; Therapeutic Equivalency; Tumor Cells, Cultured

2002